Say NO to neurodegeneration: Role of S-nitrosylation in neurodegenerative disorders

NeuroSignals

Volumn 15, Issue 6, 2007, Pages 307-313

  Chung, Kenny K K ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Neurodegeneration; Neurodegenerative disorders; Nitric oxide; S nitrosylation

Indexed keywords

CYCLIC GMP; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LIPID PEROXIDATION; NITROSYLATION; NONHUMAN; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANSCRIPTION INITIATION;

AMINO ACID MOTIFS; ANIMALS; CYCLIC GMP; CYSTEINE; DISEASE MODELS, ANIMAL; GUANYLATE CYCLASE; HUMANS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTEIN FOLDING; RECEPTORS, N-METHYL-D-ASPARTATE; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANSCRIPTION, GENETIC;

EID: 40449130443     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109071     Document Type: Review

References (44)

1. Reynolds MF, Burstyn JN: Mechanism of activation of soluble guanylyl cyclase by NO; in Ignarro L (ed): Nitric Oxide Biology and Pathobiology. San Diego, Academic Press, 2000, pp 57-82.
2. Stamler JS, Lamas S, Fang FC: Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001;106:675-683.
3. Stamler JS, Toone EJ, Lipton SA, Sucher NJ: (S)NO signals: translocation, regulation, and a consensus motif. Neuron 1997;18:691-696.
4. Knipp M, Braun O, Gehrig PM, Sack R, Vasak M: Zn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylation. J Biol Chem 2003;278:3410-3416.
5. Gaston B: Nitric oxide and thiol groups. Biochim Biophys Acta 1999;1411:323-333.
6. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS: A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 2001;410:490-494.
7. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G, McMahon TJ, Dickfeld T, Marshall HE, Que LG, Stamler JS: Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004;116:617-628.
8. Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, Koch WJ, Daaka Y, Lefkowitz RJ, Stamler JS: Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 2007;129:511-522.
9. Lieberman MW, Wiseman AL, Shi ZZ, Carter BZ, Barrios R, Ou CN, Chevez-Barrios P, Wang Y, Habib GM, Goodman JC, Huang SL, Lebovitz RM, Matzuk MM: Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 1996;93:7923-7926.
10. Chung KK, Dawson VL, Dawson TM: S-nitrosylation in Parkinson's disease and related neurodegenerative disorders. Methods Enzymol 2005;396:139-150.
11. Greco TM, Hodara R, Parastatidis I, Heijnen HF, Dennehy MK, Liebler DC, Ischiropoulos H: Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci USA 2006;45:12029-12038.
12. Hao G, Derakhshan B, Shi L, Campagne F, Gross SS: SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci USA 2006;103:1012-1017.
13. Garban HJ, Marquez-Garban DC, Pietras RJ, Ignarro LJ: Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci USA 2005;102:2632-2636.
14. Marshall HE, Hess DT, Stamler JS: S-nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci USA 2004;101:8841-8842.
15. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, van der Vliet A, Janssen-Heininger YM: Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci USA 2004;101:8945-8950.
16. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, Li CY: Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 2007;26:63-74.
17. Riccio A, Alvania RS, Lonze BE, Ramanan N, Kim T, Huang Y, Dawson TM, Snyder SH, Ginty DD: A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 2006;21:283-294.
18. Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HS, Lipton SA: Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 2000;3:15-21.
19. Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, Bankston LA: Cysteine regulation of protein function - as exemplified by NMDA-receptor modulation. Trends Neurosci 2002;25:474-480.
20. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH: Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000;28:183-193.
21. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH: Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 2001;3:193-197.
22. Yun HY, Gonzalez-Zulueta M, Dawson VL, Dawson TM: Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc Natl Acad Sci USA 1998;95:5773-5778.
23. Huang Y, Man HY, Sekine-Aizawa Y, Han Y, Juluri K, Luo H, Cheah J, Lowenstein C, Huganir RL, Snyder SH: S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors. Neuron 2005;46:533-540.
24. McMahon TJ, Moon RE, Luschinger BP, Carraway MS, Stone AE, Stolp BW, Gow AJ, Pawloski JR, Watke P, Singel DJ, Piantadosi CA, Stamler JS: Nitric oxide in the human respiratory cycle. Nat Med 2002;8:711-717.
25. Pawloski JR, Hess DT, Stamler JS: Export by red blood cells of nitric oxide bioactivity. Nature 2001;409:622-626.
26. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, Gaston B: S-nitrosothiols signal the ventilatory response to hypoxia. Nature 2001;413:171-174.
27. Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol 2000;157:1439-1445.
28. Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C, Richter-Landsberg C, Lee VM, Trojanowski JQ: Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 2003;163:1021-1031.
29. Ischiropoulos H, Beckman JS: Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003;111:163-169.
30. Schonhoff CM, Matsuoka M, Tummala H, Johnson MA, Estevez AG, Wu R, Kamaid A, Ricart KC, Hashimoto Y, Gaston B, Macdonald TL, Xu Z, Mannick JB: S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2006;103:2404-2409.
31. Boillee S, Vande Velde C, Cleveland DW: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006;52:39-59.
32. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM: Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000;290:985-989.
33. Shen J: Protein kinases linked to the pathogenesis of Parkinson's disease. Neuron 2004;44:575-577.
34. Ito G, Ariga H, Nakagawa Y, Iwatsubo T: Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1. Biochem Biophys Res Commun 2006;339:667-672.
35. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM: S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004;304:1328-1331.
36. Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, Uehara T, Lipton SA: Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA 2004;101:10810-10814.
37. Chung KK, Dawson VL, Dawson TM: New insights into Parkinson's disease. J Neurol 2003;250(suppl 3):III15-24.
38. Feany MB, Pallanck LJ: Parkin: a multipurpose neuroprotective agent? Neuron 2003;38:13-16.
39. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, Hess EJ, Dawson VL, Dawson TM: Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci USA 2004;101:10744-10749.
40. Zhang Y, Dawson VL, Dawson TM: Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 2000;7:240-250.
41. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A: S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005;7:665-674.
42. Hara MR, Thomas B, Cascio MB, Bae BI, Hester LD, Dawson VL, Dawson TM, Sawa A, Snyder SH: Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci USA 2006;103:3887-3889.
43. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA: Snitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006;441:513-517.
44. Ellgaard L, Ruddock LW: The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep 2005;6:28-32.